| 148.879 -0.081 (-0.05%) | 05-08 10:46 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 179.2 | 1-year : | 209.31 |
| Resists | First : | 153.42 | Second : | 179.2 |
| Pivot price | 145.33 |
|||
| Supports | First : | 145.35 | Second : | 140.36 |
| MAs | MA(5) : | 148.32 |
MA(20) : | 145.56  |
| MA(100) : | 151.38 |
MA(250) : | 150.2 |
|
| MACD | MACD : | -0.5 |
Signal : | -1.3 |
| %K %D | K(14,3) : | 90.1 |
D(3) : | 85.5 |
| RSI | RSI(14): 54.9 |
|||
| 52-week | High : | 161.41 | Low : | 130.27 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ FBT ] has closed below upper band by 13.6%. Bollinger Bands are 0.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 149.14 - 149.58 | 149.58 - 150.08 |
| Low: | 146.6 - 147.15 | 147.15 - 147.76 |
| Close: | 148 - 148.82 | 148.82 - 149.75 |
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
Tue, 07 May 2024
Closing Bell: First Trust NYSE Arca Biotechnology ETF up on Tuesday (FBT) - The Globe and Mail
Wed, 01 May 2024
Trend Tracker for (FBT) - Stock Traders Daily
Wed, 10 Apr 2024
FBT: An Equal Weight Way To Play Biotech (NYSEARCA:FBT) - Seeking Alpha
Fri, 27 Jan 2023
Biotech ETF (FBT) Hits New 52-Week High - Yahoo Singapore News
Mon, 16 Jan 2023
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Yahoo New Zealand News
Mon, 20 Dec 2021
Biotech ETFs That Outperformed Last Week - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|